Placental Proinflammatory State and Maternal Endothelial Dysfunction in Preeclampsia

Area of Science:

• Reproductive Immunology
• Maternal-Fetal Medicine
• Inflammatory Diseases

Background:

• Preeclampsia (PE) is a significant pregnancy complication.
• Understanding the inflammatory pathways in PE is crucial for diagnosis and treatment.
• Distinguishing between early-onset (EO) and late-onset (LO) PE may reveal different pathophysiological mechanisms.

Purpose of the Study:

• To compare placental and decidual gene expression of inflammatory markers between women with PE and normal pregnancy (NP).
• To measure maternal and umbilical serum concentrations of cytokines and adhesion molecules in PE and NP groups.
• To analyze differences in these markers between EO-PE and LO-PE.

Main Methods:

• Cross-sectional study of 50 women with PE (30 EO, 20 LO) and 50 women with NP.
• Gene expression analyzed using real-time RT-PCR.
• Serum concentrations of cytokines and adhesion molecules measured by immunoassays.

Main Results:

• PE showed lower placental interleukin-10 (IL-10) and IL-1 receptor antagonist (IL-1RA) expression, and higher placental IL-8/IL-1RA ratio and maternal vascular cell adhesion molecule-1 (VCAM-1) compared to NP.
• EO-PE exhibited lower placental IL-10 and higher placental IL-8/IL-10 and IL-8/IL-1RA ratios than LO-PE and NP.
• LO-PE had higher maternal IL-6 concentrations than EO-PE and NP. Maternal VCAM-1 was elevated in all PE cases.

Conclusions:

• Preeclampsia is associated with a proinflammatory placental state.
• Early-onset PE is characterized by placental inflammation, while late-onset PE involves systemic maternal inflammation.
• Both EO-PE and LO-PE are linked to maternal endothelial dysfunction.